RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Creo Medical Group Stock

Creo Medical Group Stocks 2024

Creo Medical Group Stocks

313 M

Ticker

CREO.L

ISIN

GB00BZ1BLL44

WKN

A2DH40

In 2024, Creo Medical Group had 313 M outstanding stocks, a 0% change from the 313 M stocks in the previous year.

The Creo Medical Group Stocks history

YEARNUMBER OF STOCKS (undefined GBP)
2029e313
2028e313
2027e313
2026e313
2025e313
2024e313
2023313
2022187.89
2021170.38
2020161.58
2019125.84
201893.78
201783.74
201683.74
201580.82
201480.74
201380.74

Creo Medical Group shares outstanding

The number of shares was Creo Medical Group in 2023 — This indicates how many shares 313.004 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Creo Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Creo Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Creo Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Creo Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Creo Medical Group Aktienanalyse

What does Creo Medical Group do?

Creo Medical Group PLC is a British medical technology company that was founded in 2003 and is based in Chepstow, Wales. The company specializes in the development and marketing of innovative medical devices. Creo Medical aims to improve the lives of healthcare professionals and patients by providing them with state-of-the-art technology. The company's business model focuses on research, development, and sales of innovative medical devices. Their goal is to provide doctors with the most advanced technology to facilitate their work. Creo Medical offers a wide range of devices for endoscopic surgery. They follow an asset-light model, outsourcing production to save costs and increase efficiency. Creo Medical was founded in 2003 by a team of professionals consisting of doctors and engineers. Their objective was to promote the development of cutting-edge technology for the medical industry and improve the treatment of patients worldwide. The company quickly gained momentum and received its first patent in 2014. Their product range includes endoscopes and electrosurgical devices for endoscopic surgery. Endoscopes are used to visualize the internal surfaces of the body through a flexible tube inserted through a small incision. This type of technology is used in surgery, particularly in gastrointestinal and gynecological areas. Electrosurgical devices are used in heart surgery and to prevent bleeding during operations. Creo Medical operates in various sectors where their products are utilized: 1. Gastroenterology: focusing on the diagnosis and treatment of digestive tract diseases. 2. Laparoscopic surgery: a surgical technique that uses a few small incisions to introduce surgical instruments into the body. 3. Gynecology: dealing with the diagnosis and treatment of diseases in the female reproductive system. 4. Urology: involving the treatment of diseases in the urinary tract and male reproductive system. Creo Medical serves multiple markets and recently announced the acquisition of Albyn Medical, a leading British manufacturer and distributor of medical devices. The company reported a 68% increase in revenue to £8.8 million in 2020, attributing the growth to growing demand for laparoscopic and gastroenterological products. Creo Medical's stock was listed on London's AIM in 2018. In conclusion, Creo Medical is a British medical technology company specializing in the development, manufacturing, and marketing of medical devices used in various medical fields. Their advanced technologies contribute to breakthroughs in surgery, making procedures more precise and gentle. Creo Medical has become a significant player in the British and international medical industry and will continue to play an important role in this sector. Creo Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Creo Medical Group's Shares Outstanding

Creo Medical Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Creo Medical Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Creo Medical Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Creo Medical Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Creo Medical Group stock

How many stocks are there of Creo Medical Group?

The current number of stocks of Creo Medical Group is 313 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Creo Medical Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Creo Medical Group evolved in recent years?

The number of shares of Creo Medical Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Creo Medical Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Creo Medical Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Creo Medical Group pay?

Over the past 12 months, Creo Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Creo Medical Group is expected to pay a dividend of 0 GBP.

What is the dividend yield of Creo Medical Group?

The current dividend yield of Creo Medical Group is .

When does Creo Medical Group pay dividends?

Creo Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Creo Medical Group?

Creo Medical Group paid dividends every year for the past 0 years.

What is the dividend of Creo Medical Group?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Creo Medical Group located?

Creo Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Creo Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Creo Medical Group from 7/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Creo Medical Group pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Creo Medical Group in the year 2023?

In the year 2023, Creo Medical Group distributed 0 GBP as dividends.

In which currency does Creo Medical Group pay out the dividend?

The dividends of Creo Medical Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Creo Medical Group

Our stock analysis for Creo Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Creo Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.